Biocon shares in focus after US FDA nod for key cancer drugs
- Posted on March 5, 2025
- By Business News Today
- 5 Views
Biocon shares in focus after US FDA nod for key cancer drugs
Biocon share price: The company also received tentative FDA approval for its ANDA for Rivaroxaban, an anticoagulant used to treat deep vein thrombosis, pulmonary embolism, and reduce stroke risk in nonvalvular atrial fibrillation.
